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ABSTRACT
Objective: The aim of this study was to analyze the nature and incidence of adverse drug reactions (ADRs) to radiographic contrast media (oral and 
intravenous) reported during a 1½ years’ period in a tertiary care hospital in South India.
Methods: The study was an observational prospective study of ADRs to radiographic contrast media (oral and intravenous) observed during a period 
of 1½ years from July 2014 to October 2015 in Department of Radio Diagnosis at Sree Balaji Medical College and Hospital, Chromepet. The observations 
were analyzed for demographic profile, frequency, severity, causality, and temporal relationship of contrast administration to the occurrence of ADRs.
Results: A total of 33 ADRs were observed for oral and intravenous radiographic contrast media administered for radiographic study for the above-
mentioned period. It included 17 (51.5%) males and 16 (48.5%) females. Among the 33 ADRs, 19 (57%) were for oral and intravenous radiographic 
contrast and 14 (42%) for intravenous radiographic contrast alone. The most frequent ADRs were vomiting and nausea 16 (48%), skin rashes 9 
(27%), and thrombophlebitis 9 (27%). As per Naranjo’s algorithm and WHO causality assessment, all reactions are probable except in one patient who 
received intravenous contrast administration was possible. According to the Hartwig severity scale, 23 (69%) reactions were mild, 7 (21%) reactions 
were moderate, and 3 (9%) reactions were severe. There was no fatality observed. Adverse events required immediate treatment in 22 (66%). Most of 
the reactions, i.e., 21 (63%) appeared immediately after contrast administration. 12 (36%) reactions appeared within next 30 minutes after contrast 
administration.
Conclusion: The common adverse reactions to radiographic contrast were mild in severity such as nausea, vomiting, skin rashes, and giddiness. 
Most of the reactions occur immediately after administration of contrast. The causality of majority of the ADRs is probable. Pharmacovigilance is an 
important tool in detection, reporting and thereby preventing ADRs due to radiographic contrast media.
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INTRODUCTION
In recent times, widespread daily use of contrast media for latest 
imaging procedures such as computed tomography (CT) and magnetic 
resonance imaging (MRI) has become mandatory. Hence, the incidence 
of adverse reactions to contrast media has increased which is not been 
reported to pharmacovigilance center in our country [1]. Voluntary 
reporting of adverse drug reactions (ADRs) has proved to be a source 
of valid information to pharmacovigilance program [2]. An integrated 
clinical, pharmaceutical, pharmacovigilance system is important in 
imparting accurate knowledge of ADRs to contrast media [3]. An 
important step in prevention of ADRs to contrast media is taking history 
of previous drug allergy, knowing the drug interaction to polypharmacy, 
especially in the elderly. Even minor adverse reactions should not be 
ignored as it may precipitate the risk of severe anaphylactic reaction on 
subsequent exposure.
Radiographic opacity of these contrast media is provided by the 
iodine [4]. Iodinated contrast media can be classified chemically into 
four categories [5]. Ionic monomers containing sodium and melamine 
which dissociates in solution to produce anion and cation hence they 
are hypertonic, for example, diatrizoate. Non-ionic monomers will not 
dissociate in solution and have less osmolality, for example, iohexol, 
iopamidol, loperamide, etc. As non-ionic dimmers, for example, 
iodixanol have an osmolality of 300 mosmols/kg of water which is 
similar to the physiological osmolality of blood, they are considered as 
iso-osmolar contrast media [6].
Not much of study was done on the pharmacovigilance of radiographic 
contrast in India; hence, this study was done in a tertiary care center 
in South India to know the causality and severity of ADRs and also to 
create awareness among medical practitioners about this new area of 
pharmacovigilance.
METHODS
This observational study was done in the Department of Radio Diagnosis, 
Sree Balaji Medical College and Hospital, Chromepet, Chennai, South 
India. The Institutional Ethical Committee approval was obtained and 
the study was conducted from July 2014 to October 2015. Patients 
undergoing radiographic imaging with contrast media were observed 
and assessed for ADRs. The observations were made for demographic 
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Table 1: Causality of ADR due to contrast media - Naranjo’s 
algorithm
Scale Inference Frequency (%)
4 Possible 1 (3.03)
5 Probable 12 (36.3)
6 Probable 10 (30.3)
7 Probable 6 (18.1)
8 Probable 4 (12.1)
Total - 33 (100)
n=33. ADR: Adverse drug reaction
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profile, frequency, causality, and severity of ADRs. For causality WHO 
causality assessment scale [7] and Naranjo’s algorithm [8] were used.
Hence both showed same results only Naranjo’s algorithm is shown in 
Table 1. Modified Hartwig and Siegel scale [9] was applied to assess the 
severity of the reported adverse reactions.
Statistical analysis
The collected data from the observations were assessed for descriptive 
statistics such as frequencies and percentages. The statistical analysis 
was done using Microsoft Excel program 2013.
RESULTS
During July 2014 to October 2015, 1893 patients received oral 
and intravenous contrast media, intravenous 720 (38%), oral and 
intravenous 1173 (62%). A total of 33 ADRs were observed among 
which 14 (42%) intravenous, 19 (58%) oral and intravenous. Among 
the patients reported ADRs, 17 (51.5%) were male and 16 (48.5%) 
were female. The mean age of patients reported with ADR is more or 
less same.
As per Naranjo’s algorithm and WHO causality assessment, all reactions 
are probable except in one patient who received intravenous contrast 
administration was possible in causality. Preexisting risk factors were 
present for 6 (18%) in oral and intravenous contrast patients. Of the 
33 patients, oral contrast used was gastrografin and intravenous 
contrast used was iopamidol. Of the 33 patients, 31 (94%) patients 
undergone CT scan and only 2 (6%) patients undergone MRI scan.
Comparison of the frequency of different ADRs between intravenous, 
and oral and intravenous is provided in Table 2. The severity of the 
ADRs is presented for intravenous and oral and intravenous contrast as 
per Hartwig and Siegel severity scale in Table 3. Among the 33 patients, 
23 (69%) developed mild reactions, 7 (21%) moderate reactions, 
and 3 (9%) severe reactions. Among the 14 intravenous contrast 
group patients, mild reactions in 10 (71%) and moderate reaction in 
4 (28.4%) were observed. Among the 19 intravenous and oral contrast 
group patients, mild reactions in 13 (68.2%) and moderate reactions 
in 3 (15.6%) were observed. The proportion of mild reactions was 
significantly higher in patients received oral and intravenous contrast 
(n=13) than those received intravenous alone (n=10). The total number 
of ADRs to both the 2 routes of administration was 23 (69%) mild 
reactions and 7 (21%) moderate reactions. When compared with the 
similar study done by Subathra et al. [4].
In our study, also mild ADRs are more than the moderate and severe 
ADRs.
The analysis of causality by Naranjo’s algorithm showed all the ADRs 
(97%) probable and only one ADR (3%) was possible. While assessing 
the time of occurrence of ADRs and administration of contrast agent, 
it was found that most of the reactions (75%) occurred immediately 
after intravenous contrast administration reactions (25%) occurred 
in 30 minutes after administration of contrast. No contrast-induced 
nephropathy was reported in our study.
DISCUSSION
According to the study published in South India [4], the incidence of 
ADRs for contrast media is 0.34%. The incidence of ADRs for non-ionic 
contrast was 0.78% (1 in 100 patients). In our study, the incidence 
for oral and intravenous contrast was 0.017%. The overall incidence 
rate reported in our study is less than in other studies. This may be 
due to less number of patients studied. The severity of ADRs as per 
Hartwig and Siegel scale for mild ADRs such as nausea, vomiting, 
cough, and skin rashes was more (68.2%) in oral and intravenous 
contrast administration than intravenous route alone. Moderate ADRs 
are slightly more in intravenous route (28.4%). Overall most of the 
ADRs fall in the severity scale of mild-to-moderate category. Only 3 
severe events (15.2%) occurred for the combined intravenous and 
oral administration. The causality assessment according to Naranjo’s 
algorithm showed the ADRs (97%) probable and only one ADR (3%) 
was possible. There are four main steps in the prevention of contrast-
induced ADRs: (1) Identify patients at risk, (2) limit the usage of 
contrast to essential cases, (3) appropriate storage, (4) administer right 
dose and route, and (5) ensure adequate hydration of the patient [10]. 
An important step in pharmacovigilance to prevent contrast-induced 
ADRs is by taking family history and history of drug allergy to identify 
the predisposing factors. The communication technology has imparted 
huge benefits to pharmacovigilance system by interlinking health-care 
professionals, pharmacists, and patients [11]. REACT is a web-based 
system which can support the radiologist in preventing ADRs due to 
contrast media [10].
CONCLUSION
The common adverse reactions to radiographic contrast were mild in 
severity such as nausea, vomiting, skin rashes, and giddiness. Most of 
the reactions occur immediately after administration of contrast. The 
causality of majority of the ADRs is probable. Pharmacovigilance is an 
important tool in detection, reporting and thereby preventing ADRs 
due to radiographic contrast media.
Table 3: Severity of adverse events in intravenous and combined oral and intravenous contrast administered patients - Hartwig and 
Siegel scale
Hartwig and Siegel scale Number of adverse drug events n (%)
Intravenous contrast Oral and intravenous contrast
Number of events Number of events Number of patients
Mild 10 (71) 3 (68.2) 23 (69)
Moderate 4 (28.4) 3 (15.6) 7 (21)
Severe 0 3 (15.2) 3 (9)
Total 14 (100) 19 (100) 33 (100) 
Sample size n=33
Table 2: Frequency of adverse events in intravenous and 
combined oral and intravenous contrast administered patients






6 (42.8) 10 (52.6) 16 (48.4)
Urticaria 4 (28.5) 5 (26.3) 9 (27.2) 
Cough, sneezing 0 1 (5.2) 1 (3)
Tightness of chest 1 (7.1) 0 1 (3)
Hypotension 0 1 (5.2) 1 (3)
Facial swelling 0 1 (5.2) 1 (3)
Thrombophlebitis 2 (14.2) 1 (5.2) 3 (9)
Bronchospasm 1 (7.1) 0 1 (3)
Total 14 (100) 19 (100) 33 (100)
Sample size n=33, ADR: Adverse drug reactions
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